In the era of systematic reviews, does the size of an individual trial still matter
- 1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. guyatt@mcmaster.ca
- 0Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. guyatt@mcmaster.ca
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sample size calculations for clinical trials remain crucial, even with the rise of systematic reviews. Small trials can yield misleading results, underscoring the importance of robust statistical planning in medical research.
Area Of Science
- Clinical Trials Methodology
- Evidence-Based Medicine
- Biostatistics
Background
- Systematic reviews represent the highest level of clinical evidence.
- The value of sample size calculations in individual clinical trials is debated.
- Small trials may present misleading findings.
Purpose Of The Study
- To evaluate the continued importance of sample size calculations in individual clinical trials.
- To address the debate surrounding the relevance of sample size in the era of systematic reviews.
Main Methods
- Review of existing literature and commentary on clinical trial design.
- Analysis of the impact of trial size on the reliability of evidence.
Main Results
- Individual clinical trials rarely offer definitive answers.
- Small sample sizes in trials can lead to potentially misleading conclusions.
Conclusions
- Sample size calculations remain essential for the integrity of individual clinical trials.
- Ensuring adequate sample size is critical for generating reliable evidence, even within the context of systematic reviews.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.